(NKTR:Consolidated Issue Listed on NASDAQ Global Select )
Jay K. Kolls M.D.
Member of Pulmonary Advisory Board, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 52 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. Jay K. Kolls, M.D. serves as Division Chief of Pediatric Pulmonoly and Director of Richard King Mellon Institute for Pediatric Research at the Children's Hospital of Ptissburgh. Prof. Kolls serves as Scientific Advisor for a handful of national and international congresses and associations on islet transplantation. He served as the Director of Gene Therapy at Louisiana State University School of Medicine. He serves as a Member of Scientific Advisory Board at MiniVax, ...
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer and Director|
Sucampo Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|